blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3752616

EP3752616 - COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING FIBRINOGEN-ALPHA [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  20.11.2020
Database last updated on 02.11.2024
FormerThe international publication has been made
Status updated on  24.08.2019
Formerunknown
Status updated on  30.03.2019
Most recent event   Tooltip27.02.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
CRISPR Therapeutics AG
Baarerstrasse 14
6300 Zug / CH
For all designated states
Bayer HealthCare LLC
100 Bayer Boulevard
Whippany, NJ 07981 / US
[2020/52]
Inventor(s)01 / BROOKS, Alan, Richard
c/o Casebia Therapeutics Limited Liability
Partnership
455 Mission Bay Boulevard South
San Francisco, CA 94158 / US
02 / VO, Karen
c/o Casebia Therapeutics Limited Liability
Partnership
455 Mission Bay Boulevard South
San Francisco, CA 94158 / US
 [2020/52]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2020/52]
Application number, filing date19712058.715.02.2019
[2020/52]
WO2019US18361
Priority number, dateUS201862710415P16.02.2018         Original published format: US 201862710415 P
[2020/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019161310
Date:22.08.2019
Language:EN
[2019/34]
Type: A1 Application with search report 
No.:EP3752616
Date:23.12.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 22.08.2019 takes the place of the publication of the European patent application.
[2020/52]
Search report(s)International search report - published on:EP22.08.2019
ClassificationIPC:C12N15/113, A61K48/00, C12N15/90
[2020/52]
CPC:
C12N15/113 (EP,US); A61K48/0008 (EP); A61K48/005 (EP);
C07K14/75 (EP); C07K14/755 (EP,US); C12N15/86 (US);
C12N15/907 (EP,US); C12N9/22 (US); C12N2310/20 (EP,US);
C12Y301/00 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/52]
Extension statesBA12.09.2020
ME12.09.2020
Validation statesKH12.09.2020
MA12.09.2020
MD12.09.2020
TN12.09.2020
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR GENEDITIERUNG DURCH TARGETING VON FIBRINOGEN-ALPHA[2020/52]
English:COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING FIBRINOGEN-ALPHA[2020/52]
French:COMPOSITIONS ET MÉTHODES POUR L'ÉDITION GÉNIQUE PAR CIBLAGE DU FIBRINOGÈNE-ALPHA[2020/52]
Entry into regional phase12.09.2020National basic fee paid 
12.09.2020Designation fee(s) paid 
12.09.2020Examination fee paid 
Examination procedure12.09.2020Examination requested  [2020/52]
12.09.2020Date on which the examining division has become responsible
06.04.2021Amendment by applicant (claims and/or description)
Fees paidRenewal fee
25.02.2021Renewal fee patent year 03
25.02.2022Renewal fee patent year 04
27.02.2023Renewal fee patent year 05
27.02.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]WO2016011080  (UNIV CALIFORNIA [US]) [X] 65-68 * claims 50-54; sequences 62668, 62675 * [A] 1-64,69-73;
 [XA]WO2017074526  (SANGAMO BIOSCIENCES INC [US]) [X] 65,69-73 * figures 10-14 * * the whole document * [A] 1-64,66-68;
 [XA]WO2015089077  (SANGAMO BIOSCIENCES INC [US]) [X] 65,69-73 * figure 2 * * the whole document * [A] 1-64,66-68;
 [XAI]  - T. O. AUER ET AL, "Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair", GENOME RESEARCH, US, (20131031), vol. 24, no. 1, doi:10.1101/gr.161638.113, ISSN 1088-9051, pages 142 - 153, XP055237091 [X] 65,69,70 * figure 1 * * the whole document * [A] 1-64,66-68 [I] 71-73

DOI:   http://dx.doi.org/10.1101/gr.161638.113
 [XAI]  - XIANGJUN HE ET AL, "Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair", NUCLEIC ACIDS RESEARCH, (20160204), vol. 44, no. 9, doi:10.1093/nar/gkw064, ISSN 0305-1048, pages e85 - e85, XP055415869 [X] 65,69,70 * figure 2 * * the whole document * [A] 1-64,66-68 [I] 71-73

DOI:   http://dx.doi.org/10.1093/nar/gkw064
 [XAI]  - CHEN SIDI ET AL, "Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis", CELL, ELSEVIER, AMSTERDAM, NL, (20150305), vol. 160, no. 6, doi:10.1016/J.CELL.2015.02.038, ISSN 0092-8674, pages 1246 - 1260, XP029203797 [X] 65 * figure 5 * * the whole document * [A] 1-64,69-73 [I] 65-68

DOI:   http://dx.doi.org/10.1016/j.cell.2015.02.038
 [A]  - R. SHARMA ET AL, "In vivo genome editing of the albumin locus as a platform for protein replacement therapy", BLOOD, US, (20151008), vol. 126, no. 15, doi:10.1182/blood-2014-12-615492, ISSN 0006-4971, pages 1777 - 1784, XP055354026 [A] 1-73 * the whole document *

DOI:   http://dx.doi.org/10.1182/blood-2014-12-615492
by applicantUS2014068797
 WO2013176772
 US5034506
 US3687808
 US4469863
 US4476301
 US5023243
 US5177196
 US5188897
 US5264423
 US5276019
 US5278302
 US5286717
 US5321131
 US5399676
 US5405939
 US5453496
 US5455233
 US5466677
 US5476925
 US5519126
 US5536821
 US5541306
 US5550111
 US5563253
 US5571799
 US5587361
 US5625050
 US5166315
 US5185444
 US5214134
 US5216141
 US5235033
 US5264562
 US5264564
 US5405938
 US5434257
 US5470967
 US5489677
 US5541307
 US5561225
 US5596086
 US5602240
 US5610289
 US5608046
 US5618704
 US5623070
 US5663312
 US5633360
 US5677437
 US5677439
 US5539082
 US5714331
 US5719262
 US4845205
 US5130302
 US5134066
 US5175273
 US5367066
 US5432272
 US5457187
 US5459255
 US5484908
 US5502177
 US5525711
 US5552540
 US5587469
 US5596091
 US5614617
 US5681941
 US5750692
 US5763588
 US5830653
 US6005096
 US2003158403
 US4828979
 US4948882
 US5218105
 US5525465
 US5541313
 US5545730
 US5552538
 US5578717
 US5580731
 US5591584
 US5109124
 US5118802
 US5138045
 US5414077
 US5486603
 US5512439
 US5578718
 US4587044
 US4605735
 US4667025
 US4762779
 US4789737
 US4824941
 US4835263
 US4876335
 US4904582
 US4958013
 US5082830
 US5112963
 US5214136
 US5245022
 US5254469
 US5258506
 US5262536
 US5272250
 US5292873
 US5317098
 US5371241
 US5391723
 US5416203
 US5451463
 US5510475
 US5512667
 US5514785
 US5565552
 US5567810
 US5574142
 US5585481
 US5587371
 US5595726
 US5597696
 US5599923
 US5599928
 US5688941
 US6287860
 WO0183692
 US5173414
 WO9513365
 US5658776
 WO9513392
 WO9617947
 WO9709441
 WO9708298
 WO9721825
 WO9706243
 WO9911764
 US5786211
 US5871982
 US6258595
    - GRIMM et al., J Virol, vol. 80, pages 426 - 439
    - COLELLA et al., Mol Ther Methods Clin Dev, (20180000), vol. 8, pages 87 - 104
    - "Gene Expression Technology", GOEDDEL, Methods in Enzymology, Academic Press, (19900000), vol. 185
    - JINEK et al., Science, (20120000), vol. 337, no. 6096, pages 816 - 821
    - Science, (20120000), vol. 337, no. 6096, pages 816 - 821
    - JINEK et al., Science, (20120000), vol. 337, pages 816 - 821
    - DELTCHEVA et al., Nature, (20110000), vol. 471, pages 602 - 607
    - MA, H. et al., Molecular Therapy - Nucleic Acids, (20140000), vol. 3, page el61
    - SAPRANAUSKAS et al., Nucleic Acids Res, (20110000), vol. 39, no. 21, pages 9275 - 9282
    - Nature Biotechnology, (20140000), vol. 32, pages 347 - 355
    - FONFARA et al., Nucleic Acids Research, (20140000), vol. 42, pages 2577 - 2590
    - NATHWANI AC, GRAY JT, NG CY et al., Blood., (20060000), vol. 107, no. 7, pages 2653 - 2661
    - WARD NJ; BUCKLEY SM; WADDINGTON SN et al., Blood., (20110000), vol. 117, no. 3, pages 798 - 807
    - RADCLIFFE PA; SION CJ; WILKES FJ et al., Gene Ther., (20080000), vol. 15, no. 4, pages 289 - 297
    - GAO et al., Nucleic Acids Research, (20080000), vol. 36, pages 2257 - 2267
    - COLGAN et al., Genes Dev., (19970000), vol. 11, pages 2755 - 2766
    - LEVITT N et al., Genes Dev, (19890000), vol. 3, no. 7, pages 1019 - 1025
    - NAKAI et al., J Virol, (20010000), vol. 75, pages 6969 - 6976
    - CRISTEA et al., Biotechnol Bioeng, (20130000), vol. 110, pages 871 - 880
    - SUZUKI et al., Nature, (20170000), vol. 540, pages 144 - 149
    - DE MESMAEKER et al., Ace. Chem. Res., (19950000), vol. 28, pages 366 - 374
    - NIELSEN et al., Science, (19910000), vol. 254, page 1497
    - BRAASCH; DAVID COREY, Biochemistry, (20020000), vol. 41, no. 14, pages 4503 - 4510
    - Heasman, Dev. Biol, (20020000), vol. 243, pages 209 - 214
    - NASEVICIUS et al., Nat. Genet., (20000000), vol. 26, pages 216 - 220
    - LACERRA et al., Proc. Natl. Acad. Sci., (20000000), vol. 97, pages 9591 - 9596
    - WANG et al., J. Am. Chem. Soc., (20000000), vol. 122, pages 8595 - 8602
    - MARTIN et al., Helv Chim Acta, (19950000), vol. 78, page 486
    - NIELSEN et al., Science, (19910000), vol. 254, pages 1497 - 1500
    - KORNBERG, A., DNA Replication, W. H. Freeman & Co., (19800000), pages 75 - 77
    - GEBEYEHU et al., Nucl Acids Res., (19970000), vol. 15, page 4513
    - SANGHVI, Y. S., Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278
    - The Concise Encyclopedia of Polymer Science And Engineering, John Wiley & Sons, (19900000), pages 858 - 859
    - ENGLISCH et al., Angewandle Chemie, International Edition, (19910000), vol. 30, page 613
    - SANGHVI, Y. S., Antisense Research and Applications, CRC Press, (19930000), pages 289 - 302
    - Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278
    - LETSINGER et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 6553 - 6556
    - MANOHARAN et al., Bioorg. Med. Chem. Let., (19940000), vol. 4, pages 1053 - 1060
    - MANOHARAN et al., Ann. N. Y. Acad. Sci., (19920000), vol. 660, pages 306 - 309
    - MANOHARAN et al., Bioorg. Med. Chem. Let., (19930000), vol. 3, pages 2765 - 2770
    - OBERHAUSER et al., Nucl. Acids Res., (19920000), vol. 20, pages 533 - 538
    - KABANOV et al., FEBS Lett., (19900000), vol. 259, pages 327 - 330
    - SVINARCHUK et al., Biochimie, (19930000), vol. 75, pages 49 - 54
    - MANOHARAN et al., Tetrahedron Lett., (19950000), vol. 36, pages 3651 - 3654
    - SHEA et al., Nucl. Acids Res., (19900000), vol. 18, pages 3777 - 3783
    - MANCHARAN et al., Nucleosides & Nucleotides, (19950000), vol. 14, pages 969 - 973
    - MISHRA et al., Biochim. Biophys. Acta, (19950000), vol. 1264, pages 229 - 237
    - CROOKE et al., J. Pharmacol. Exp. Ther., (19960000), vol. 277, pages 923 - 937
    - HU et al., Protein Pept Lett., (20140000), vol. 21, no. 10, pages 1025 - 30
    - KORMANN et al., Nature Biotechnology, (20110000), vol. 29, pages 154 - 157
    - WARREN et al., Cell Stem Cell, (20100000), vol. 7, no. 5, pages 618 - 30
    - ANGART et al., Pharmaceuticals (Basel, (20130000), vol. 6, no. 4, pages 440 - 468
    - KANASTY et al., Molecular Therapy, (20120000), vol. 20, no. 3, pages 513 - 524
    - BURNETT et al., Biotechnol J., (20110000), vol. 6, no. 9, pages 1130 - 46
    - JUDGE; MACLACHLAN, Hum Gene Ther, (20080000), vol. 19, no. 2, pages 111 - 24
    - WHITEHEAD KA et al., Annual Review of Chemical and Biomolecular Engineering, (20110000), vol. 2, pages 77 - 96
    - GAGLIONE; MESSERE, Mini Rev Med Chem, (20100000), vol. 10, no. 7, pages 578 - 95
    - CHERNOLOVSKAYA et al., Curr Opin Mol Ther., (20100000), vol. 12, no. 2, pages 158 - 67
    - BEHLKE, Oligonucleotides, (20080000), vol. 18, no. 4, pages 305 - 19
    - FUCINI et al., Nucleic Acid Ther, (20120000), vol. 22, no. 3, pages 205 - 210
    - BREMSEN et al., Front Genet, (20120000), vol. 3, page 154
    - KOLE, Nature Reviews Drug Discovery, (20120000), vol. 11, pages 125 - 140
    - SOUTSCHEK et al., Nature, (20040000), vol. 432, pages 173 - 178
    - VOLKOV, Oligonucleotides, (20090000), vol. 19, pages 191 - 202
    - JUDGE et al., Mol. Ther., (20060000), vol. 13, pages 494 - 505
    - CEKAITE et al., J. Mol. Biol., (20070000), vol. 365, pages 90 - 108
    - KARIKO, K. et al., Immunity, (20050000), vol. 23, pages 165 - 175
    - WINKLER, Ther. Deliv., (20130000), vol. 4, pages 791 - 809
    - PEER; LIEBERMAN, Gene Therapy, (20110000), vol. 18, pages 1127 - 1133
    - LOVE et al., PNAS, (20100000), vol. 107, pages 1864 - 1869
    - SAMULSKI et al., Proc. Natl. Acad. S6. USA, (19820000), vol. 79, pages 2077 - 2081
    - LAUGHLIN et al., Gene, (19830000), vol. 23, pages 65 - 73
    - SENAPATHY; CARTER, J. Biol. Chem., (19840000), vol. 259, pages 4661 - 4666
    - CARTER, Current Opinions in Biotechnology, (19920000), pages 1533 - 539
    - MUZYCZKA, Curr. Topics in Microbial. and Immunol., (19920000), vol. 158, pages 97 - 129
    - RATSCHIN et al., Mol. Cell. Biol., (19840000), vol. 4, page 2072
    - HERMONAT et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, page 6466
    - TRATSCHIN et al., Mol. Cell. Biol., (19850000), vol. 5, page 3251
    - MCLAUGHLIN et al., J. Virol., (19880000), vol. 62, page 1963
    - LEBKOWSKI et al., Mol. Cell. Biol., (19880000), vol. 7, page 349
    - SAMULSKI et al., J. Virol., (19890000), vol. 63, pages 3822 - 3828
    - PERRIN et al., Vaccine, (19950000), vol. 13, pages 1244 - 1250
    - PAUL et al., Human Gene Therapy, (19930000), vol. 4, pages 609 - 615
    - CLARK et al., Gene Therapy, (19960000), vol. 3, pages 1124 - 1132
    - SEGAL et al., Proc Natl Acad Sci USA, (19990000), vol. 96, no. 6, pages 2758 - 63
    - DREIER B et al., J Mol Biol., (20000000), vol. 303, no. 4, pages 489 - 502
    - LIU Q et al., J Biol Chem., (20020000), vol. 277, no. 6, pages 3850 - 6
    - DREIER et al., J Biol Chem, (20050000), vol. 280, no. 42, pages 35588 - 97
    - DREIER et al., J Biol Chem., (20010000), vol. 276, no. 31, pages 29466 - 78
    - BOCH, Science, (20090000), vol. 326, no. 5959, pages 1509 - 12
    - MAK et al., Science, (20120000), vol. 335, no. 6069, pages 716 - 9
    - MOSCOU et al., Science, (20090000), vol. 326, no. 5959, page 1501
    - CERMAK et al., Nucleic Acids Res., (20110000), vol. 39, no. 12, page 82
    - LI et al., Nucleic Acids Res., (20110000), vol. 39, no. 14, pages 6315 - 25
    - WEBER et al., PLoS One., (20110000), vol. 6, no. 2, page el6765
    - WANG et al., J Genet Genomics, (20140000), vol. 41, no. 6, pages 339 - 47
    - CERMAK T et al., Methods Mol Biol., (20150000), vol. 1239, pages 133 - 59
    - STEENTOFT et al., Glycobiology, (20140000), vol. 24, no. 8, pages 663 - 80
    - BELFORT; BONOCORA, Methods Mol Biol., (20140000), vol. 1123, pages 1 - 26
    - HAFEZ; HAUSNER, Genome, (20120000), vol. 55, no. 8, pages 553 - 69
    - BOISSEL et al., NAR, (20140000), vol. 42, pages 2591 - 2601
    - KLEINSTIVER et al., G3, (20140000), vol. 4, pages 1155 - 65
    - BOISSEL; SCHARENBERG, Methods Mol. Biol., (20150000), vol. 1239, pages 171 - 96
    - WOLFS et al., NAR, (20140000), vol. 42, pages 8816 - 29
    - TSAI et al., Nature Biotech, (20140000), vol. 32, pages 569 - 76
    - GUILINGER et al., Nature Biotech., (20140000), vol. 32, pages 577 - 82
    - STEMMER M; THUMBERGER T; DEL SOL KEYER M; WITTBRODT J; MATEO JL, "CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool", PLoS ONE, vol. 10, no. 4, (20150000), page e0124633, URL: https://doi.org/10.1371/journal.pone.0124633
    - BRINKMAN et al., Nucleic Acids Research, vol. 42, page 168
    - SUZUKI et al., Nature, (20160000), vol. 540, page l44
    - AUER, T. O. et al., Genome research, (20140000), vol. 24, no. 1, pages 142 - 153
    - MAO, Z. et al., Cell cycle, (20080000), vol. 7, no. 18, pages 2902 - 2906
    - MARESCA, M. et al., Genome research, (20130000), vol. 23, no. 3, pages 539 - 546
    - CRISTEA, S. et al., Biotechnology and bioengineering, (20130000), vol. 110, no. 3, pages 871 - 880
    - STEMMER, M. et al., PloS One, (20150000), vol. 10, no. 4, page e0124633
    - BRINKMAN, E. K.; CHEN, T.; AMENDOLA, M.; VAN STEENSEL, B., Nucleic acids research, (20140000), vol. 42, no. 22, pages el68 - el68
    - ANDERSON et al., Journal of Biotechnology, (20150000), vol. 211, pages 56 - 65
    - LOVE, K. T.; MAHON, K. P.; LEVINS, C. G.; WHITEHEAD, K. A.; QUERBES, W.; DORKIN, J. R.; FRANK-KAMENETSKY, M., Proceedings of the National Academy of Sciences, (20100000), vol. 107, no. 5, pages 1864 - 1869
    - COPPOLA et al., J Blood Med., (20100000), vol. 1, pages 183 - 195
    - LEVITT et al., GENES & DEVELOPMENT, (19890000), vol. 3, pages 1019 - 1025
    - BI L; LAWLER AM; ANTONARAKIS SE; HIGH KA; GEARHART JD; KAZAZIAN HH JR., Nat Genet, (19950000), vol. 10, no. 1, pages 119 - 21
    - MCINTOSH, J. et al., Blood, (20130000), vol. 121, pages 3335 - 44
    - QUAN, P. L. et al., Sensors, (20180000), vol. 18, page 1271
    - TSAI et al., Nat Biotechnol, (20150200), vol. 33, no. 2, pages 187 - 197
    - CHIP-SEQ, Nature Biotechnology, (20140000), vol. 32, pages 677 - 683
    - TSAI et al., Nature Biotech, (20150000), vol. 33, pages 187 - 197
    - BRINKMAN et al., Nucleic Acids Research, (20140000), vol. 1
    - Levitt Int J Gen Med, vol. 9, pages 229 - 255
    - OSWALD et al., Am J Med Technol., (19830000), vol. 49, pages 57 - 59
    - WANG et al., Nat Rev Genet., (20090000), vol. 10, pages 57 - 63
    - FAGERBERG et al., Mol Cell Proteomics., (20140200), vol. 13, no. 2, pages 397 - 406
    - ZAIAS et al., J American Association for Laboratory Animal Science, vol. 48, pages 387 - 390
    - MACHLUS et al., Blood, (20110000), vol. 117, pages 4953 - 4963
 WO1992US09196
 WO1998US18600
 WO1996US14423
 WO1996US13872
 WO1996US20777
 WO1996FR01064
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.